NEXT-GENERATION MODULATORS OF STIMULATOR OF INTERFERON GENES (STING)

The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceut...

Full description

Saved in:
Bibliographic Details
Main Authors DUDEK, LUKASZ PIOTR, ROGACKI, MACIEJ KRZYSZTOF, TOPOLNICKI, GRZEGORZ WITOLD, GLUZA, KAROLINA MARIA, DOBRZANSKA, MONIKA PATRYCJA, FABRITIUS, CHARLES-HENRY, CWIERTNIA, GRZEGORZ WOJCIECH, GIBAS, AGNIESZKA JUSTYNA, RAJDA, ANNA, SUDOL, SYLWIA, ZAWADZKA, MAGDALENA IZABELA, STASI, LUIGI PIERO
Format Patent
LanguageEnglish
French
Published 28.11.2023
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds of formula (I) and salts, stereoisomers, tautomers or N-oxides thereof that are useful as modulators of STING (Stimulator of Interferon Genes). The present invention further relates to the compounds of formula (I) for use as a medicament and to a pharmaceutical composition comprising said compounds. La présente invention concerne des composés de formule (I) et des sels, des stéréoisomères, des tautomères ou des N-oxydes de ceux-ci, utilisables comme modulateurs de STING (stimulateur de gènes d'interféron). La présente invention concerne en outre les composés de formule (I) destinés à être utilisés comme médicament et une composition pharmaceutique comprenant lesdits composés.
Bibliography:Application Number: CA20203140257